Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Coliseum Capital Takes Some Profit From Its LHC Group, Inc. (LHCG) Holding; More On The Way?

In a recent 13D filing with the Securities and Exchange Commission, it was disclosed that Christopher Shackelton and Adam Gray‘s Coliseum Capital has trimmed its stake in LHC Group, Inc. (NASDAQ:LHCG) to about 2.17 million shares from 2.27 million shares that it held previously. The current holding represents 12.05% of the company’s outstanding common stock.

Tarchyshnik Andrei/

Tarchyshnik Andrei/

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 142% and beating the market by more than 84 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise (while avoiding their high fees at the same time) rather than large-cap stocks.

After working for Watershed Asset Management, Christopher Shackelton, a graduate from Yale, co-founded Coliseum in 2005. The investment firm makes long-term investments in both public and private companies. It has a concentrated portfolio with eight public equity holdings, the market value of which stood at $331.88 million at the end of March. The healthcare sector represented 63% of those holdings. Currently, Coliseum has about $757 million in assets under management.

The $652.42 million provider of post-acute health care services to hospitals, physicians and families has seen its stock soar by nearly 20% year-to-date. This is even better than the strong gains of the medical care industry, which amount to 13.5% during the same period. The trailing twelve month earnings multiple of LHC Group, Inc. (NASDAQ:LHCG) stands at 25.8, and is lower than the industry’s average of 27.09. However, its beta of 1.17 is significantly higher than the industry’s 0.45.